Doubling Time of Carcinoembryonic Antigen Is a Significant Prognostic Factor after the Surgical Resection of Locally Recurrent Rectal Cancer

Background: Patients undergoing a curative rectal cancer resection have a risk of developing locoregional recurrence. A curative resection for local recurrence is the option of improvement in prognosis. However, a curative resection is sometimes too invasive and should be considered in selected patients. Methods: A total of 43 patients with locally recurrent rectal cancer who had been treated by operation between 1989 and 2007 were retrospectively reviewed and the factors, including doubling time of carcinoembryonic antigen (CEA-dt), were analyzed. Results: The 5-year overall survival rate after the operation for local recurrence was 50.8%. Gender, presence of distant metastasis, tumor size, CEA-dt and curability were found to be significant prognostic factors. A multivariate analysis demonstrated the presence of distant metastasis, CEA-dt and tumor size to be significant prognostic factors for overall survival. The 5-year overall survival rates of patients with a CEA-dt ≧150 days and a tumor size <5 cm were 76.9%. Conclusions: The tumor size and CEA-dt were useful prognostic factors that were recognizable before surgery. Patients with locally recurrent rectal cancer with a CEA-dt ≧150 days and a recurrent tumor size <5 cm are considered to be good candidates for surgery.

[1]  V. Ozmen,et al.  Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience. , 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[2]  H. Putter,et al.  The TME Trial After a Median Follow-up of 6 Years: Increased Local Control But No Survival Benefit in Irradiated Patients With Resectable Rectal Carcinoma , 2007, Annals of surgery.

[3]  Riwa Kishimoto,et al.  Clinical Results of Carbon Ion Radiotherapy at NIRS. , 2007, Journal of radiation research.

[4]  K. Giercksky,et al.  [Treatment of locally recurrent rectal cancer]. , 2007, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[5]  H. Eguchi,et al.  [A case of high-dose rate interstitial brachytherapy for locally recurrent rectal cancer]. , 2006, Gan to kagaku ryoho. Cancer & chemotherapy.

[6]  Andreas Makris,et al.  Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival? , 2005, International journal of radiation oncology, biology, physics.

[7]  L. Ben-Porat,et al.  Operative Salvage for Locoregional Recurrent Colon Cancer After Curative Resection: An Analysis of 100 Cases , 2005, Diseases of the colon and rectum.

[8]  A. Eggermont,et al.  Preoperative Radiotherapy Improves Outcome in Recurrent Rectal Cancer , 2005, Diseases of the colon and rectum.

[9]  N. Mulder,et al.  Treatment of locally recurrent rectal cancer, results and prognostic factors. , 2004, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[10]  I. Kanellos,et al.  Locally recurrent rectal cancer after curative resection , 2004, Techniques in Coloproctology.

[11]  I. Endo,et al.  Metastatic Tumor Doubling Time: Most Important Prehepatectomy Predictor of Survival and Nonrecurrence of Hepatic Colorectal Cancer Metastasis , 2004, World Journal of Surgery.

[12]  R. Beart,et al.  Use of High-Dose-Rate Brachytherapy in the Management of Locally Recurrent Rectal Cancer , 2003, Diseases of the colon and rectum.

[13]  H. Shimada,et al.  Outcome of total pelvic exenteration for locally recurrent rectal cancer. , 2003, Hepato-gastroenterology.

[14]  S. Cha,et al.  Curative Potential of Multimodality Therapy for Locally Recurrent Rectal Cancer , 2003, Annals of surgery.

[15]  G. Noël,et al.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer , 2002 .

[16]  J. Guillem,et al.  Predictors of Survival in Recurrent Rectal Cancer After Resection and Intraoperative Radiotherapy , 2002, Diseases of the colon and rectum.

[17]  K. Giercksky,et al.  Preoperative irradiation and surgery for recurrent rectal cancer. Will intraoperative radiotherapy (IORT) be of additional benefit? A prospective study. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  D. Rothenberger,et al.  Treatment of locally recurrent rectal cancer , 2001, Diseases of the colon and rectum.

[19]  Rieken,et al.  [Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer]. , 2001, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[20]  V. Fazio,et al.  Locally Recurrent Rectal Cancer: Predictors and Success of Salvage Surgery , 2001 .

[21]  M. Imamura,et al.  Pathologic significance of tumor progression in locally recurrent rectal cancer , 2000, Diseases of the colon and rectum.

[22]  K. Matzel,et al.  Extensive surgery after high-dose preoperative chemoradiotherapy for locally advanced recurrent rectal cancer , 2000, Diseases of the colon and rectum.

[23]  Yoichi Tanaka,et al.  Intraoperative irradiation after surgery for locally recurrent rectal cancer , 1999, Diseases of the colon and rectum.

[24]  T. Akasu,et al.  The relationship between prognosis and CEA-dt after hepatic resection in patients with colorectal carcinomas. , 1999, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[25]  S. I. Cohen,et al.  Pelvic resection of recurrent rectal cancer: technical considerations and outcomes. , 1999, Diseases of the Colon & Rectum.

[26]  J. Guillem,et al.  Surgical Salvage of Recurrent Rectal Carcinoma After Curative Resection: a 10-Year Experience , 1999, Annals of Surgical Oncology.

[27]  V. Bardou,et al.  Surgical resection of locally recurrent colorectal adenocarcinoma , 1998, The British journal of surgery.

[28]  R. Wong,et al.  In search of a dose-response relationship with radiotherapy in the management of recurrent rectal carcinoma in the pelvis: a systematic review. , 1998, International journal of radiation oncology, biology, physics.

[29]  S. Andreola,et al.  Surgical treatment of locally recurrent rectal carcinoma , 1997, Diseases of the colon and rectum.

[30]  W. Enker,et al.  Salvage therapy for pelvic recurrence following curative rectal cancer resection , 1997, Diseases of the colon and rectum.

[31]  A. Weaver,et al.  Curative reoperations for locally recurrent rectal cancer , 1996, Diseases of the colon and rectum.

[32]  M. Hershman,et al.  Prognostic factors in surgery for local recurrence of rectal cancer , 1995, The British journal of surgery.

[33]  L. Påhlman,et al.  Treatment of local recurrences of rectal carcinoma. , 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[34]  H. Wanebo,et al.  Pelvic resection of recurrent rectal cancer , 1994, Annals of surgery.

[35]  J. Mcgregor,et al.  Local recurrence of colorectal cancer: The problem, mechanisms, management and adjuvant therapy , 1994, The British journal of surgery.

[36]  R. Fischer,et al.  Doubling time of circulating cea and its relation to survival of patients with recurrent colorectal cancer. , 1982, British Journal of Cancer.

[37]  J. Welch,et al.  Detection and treatment of recurrent cancer of the colon and rectum. , 1978, American journal of surgery.

[38]  V. P. Collins,et al.  Observations on growth rates of human tumors. , 1956, The American journal of roentgenology, radium therapy, and nuclear medicine.